Stay updated on Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.

Latest updates to the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe PubMed publication note text was updated to say publications are automatically filled in from PubMed, replacing the previous wording; the page revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page no longer displays the government funding/operating status notice, and this deletion does not alter the study details, eligibility criteria, enrollment, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedThe Study Details page shows updated information including the Last Update posted date, enrollment numbers, and primary completion date, with revised results and publications sections.SummaryDifference0.3%

- Check63 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check70 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' removed (minor UI change).SummaryDifference0.1%

Stay in the know with updates to Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.